The MMP-9/MMP-13 Inhibitor I is primarily used in research settings to study the role of matrix metalloproteinases (MMPs) in various biological processes. It is particularly valuable in investigating conditions where MMP-9 and MMP-13 are overexpressed, such as in cancer metastasis, arthritis, and other inflammatory diseases. By inhibiting these enzymes, researchers can better understand their contribution to tissue remodeling, degradation of extracellular matrix components, and disease progression. This inhibitor is also utilized in drug development studies aimed at creating therapeutic agents for conditions involving excessive MMP activity. Its application extends to preclinical models where it helps evaluate the potential efficacy of MMP-targeting treatments.